In contrast, Myr (300 mg/kg) treatment could reduce renal inflammation by reducing the expressions of cytosolic P-IκBα (p < 0.01) and nuclear P-NF-κB (p < 0.01) in the kidneys of T2D rats (Figure 12c,d). This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.